NCI

1336
36.9400.33% ( +0.120 )
Delay Closed: Nov 16, 16:08:11

Overview

NCI (1336)

New China Life Insurance Company Ltd. provides life insurance products and services to individuals and institutions in China. The company operates through three...

Open
36.800
High
37.200
Low
36.440
Prev. Close
36.820
Volume
6.25M
Turnover
230.82M
Avg Price
36.917
Bid/Ask Ratio
-93.03%
Amplitude
2.06%
52wk High
62.579
Volume Ratio
0.56
Turnover Ratio
0.60%
52wk Low
36.428
HK Mkt Cap
38.20B
Market CapHKD
115.24B
P/ETTM
3.85
P/EDynamic
3.33
P/EStatic
--
EPSTTM
9.60
EPSDynamic
11.09
EPSStatic
--
BVPS
48.12
P/B
0.77
HK Shares
1.03B
Dividend YieldTTM
8.72%
DividendTTM
3.221
Shares
3.12B
Min lot size
100
Currency
HKD

NCI Analyst Rating

View more

Forecast & Rating

Nov 11, 2026
Price forecast
HK$49.1032.91%
Forecast & RatingHold
12analysts
  • Strong buy25.00%
  • Buy8.33%
  • Hold41.67%
  • Sell16.67%
  • Strong sell8.33%

Daily Events

  1. Oct, 22

    New China Life fell about 3.3% on Thursday, opening at its HK$39.76 session high before sliding to a 52-week low of HK$37.70 in the afternoon and settling at HK$38.20, as mainland insurers weakened ahead of next week's Q3 reporting cluster on concerns over equity-market volatility and a high prior-year base. The tension with fundamentals is stark: Q2 EPS reached HK$6.042, up 93.6% yoy, with net profit of HK$18.82bn (+92.6%), yet the stock is down 32.03% year-to-date, sits 41.95% below its January 28 high of HK$65.80, and trades under its MA20 of 43.67 and MA60 of 46.17, at PE 2.34 and PB 0.84. Institutions point to the high-dividend theme, and NCI has again added to its AVICHINA H-share stake, though nearly 80% of equity-type insurance asset-management products lost money in Q3, keeping sector sentiment subdued.

  2. Oct, 20

    New China Life fell 4.70% to HK$40.12 on October 20, spiking early to HK$41.78 before sliding to HK$39.52 in the afternoon — nearly retesting its 52-week low of HK$39.50 — as the sector prices in next week's clustered third-quarter results, with institutions flagging that the quarter's equity-market pullback and claims pressure could weigh heavily on profits, and that nearly 80% of insurer equity asset-management products lost money in Q3. The stock is down 28.61% year to date, 39.03% below its January 28 high of HK$65.80, and trades under both MA20 (HK$44.52) and MA60 (HK$46.48). Fundamentals read differently: Q2 EPS was HK$6.042 and net profit HK$18.82bn, up 93.63% and 92.59% year on year, on a PE of 2.46x. Donghai Securities, though, sees the dividend-insurance overhaul supporting a more stable liability structure.

  3. Oct, 15

    New China Life fell about 2% to HK$42.76 in a high-open, low-close session, as mainland insurers extended their pullback on concern that Q3 equity market weakness and property-casualty claims will weigh on earnings. After opening at HK$43.58, it peaked at HK$43.10 in the morning session and slid to HK$42.24 in the afternoon, near its 52-week low of HK$42.22; it is down 23.91% year-to-date, 35.02% below the January high of HK$65.80, and sits under MA20 (HK$45.13) and MA60 (HK$46.74). Fundamentals run the other way: Q2 2026 EPS of HK$6.042 rose 93.63% yoy, net profit of HK$18.818bn gained 92.59%, revenue of HK$32.492bn rose 46.61%, with a 2.62x P/E, 0.94x P/B and a 7.26% dividend yield. NCI lifted its stake in Guotai Haitong H-shares to 20.24%, while a super El Nino may lift claims, though institutions see Q3 as the year's profit trough.

  4. Oct, 8

    New China Life closed up 1.27% at HK$44.78 after a spike-and-fade session: it touched HK$45.62 at 10:06 BJ in the morning session, retested HK$45.30 at 13:11 without holding, and settled at the day's low of HK$44.78 on HK$262.3 million turnover and a 0.56% turnover rate. The lift traces to fundamentals — 1H26 net profit rose 54% YoY to RMB22.79 billion and revenue 18.9% to RMB83.26 billion, while Q2 standalone net profit reached HK$18.80 billion, up 92.66% YoY, with EPS of HK$6.0373 (+93.7%). The stock nonetheless sits below its MA20 (HK$45.98) and MA60 (HK$47.02), down 20.32% YTD and 31.95% below the 52-week high of HK$65.8 set on 28 January, only 5.12% above the 52-week low of HK$42.6, at 2.74x PE and 0.98x PB; Morgan Stanley earlier raised its target price to HK$39.9 with an Underweight rating.

  5. Oct, 2

    New China Life (1336.HK) opened lower and slid through the Oct 2 morning session, touching its day low of HK$43.30 at the close versus HK$45.02 prior, down about 3.8% on HK$19.7 million turnover, as the market digested an interim report showing net profit up 54% YoY to RMB22.79 billion, revenue up 18.9% to RMB83.26 billion and an interim DPS of RMB0.73, with Morgan Stanley's target price at HK$39.9. The stock sits near the bottom of its 52-week range of HK$41.46-65.80, down 34.19% from the January high and 4.44% above the low, off 22.95% year to date and below MA20 of HK$46.85 and MA60 of HK$47.08, at 2.65x PE and 0.95x PB. Though earnings momentum persists, with Q2 EPS of HK$6.0373 up 93.7% YoY and second-quarter net profit of RMB18.80 billion up 92.66%.

News

Bullish vs. Bearish — Last 3 Months

5.9k followers · 0 opinions
▲Bullish50%
50%Bearish▼